EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Revolutionizing Antimicrobial Therapies Through Biofilm-Targeted Nanomedicine

Robin Singh

Current Pharmaceutical Research · 2025

DOI: 10.63785/cpr.2025.1.1.7897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Pharmaceutical Research, 2025. Verfasst von Robin Singh. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Revolutionizing Antimicrobial Therapies Through Biofilm-Targeted Nanomedicine. Biofilmassociated infections pose significant challenges to traditional antimicrobial therapies due to their inherent resistance mechanisms and protective extracellular matrix. Nanomedicine offers transformative solutions by providing innovative strategies to target, penetrate, and disrupt biofilms effectively. Recent advancements in nanotechnology have enabled the development of multifunctional nanocarriers, hybrid nanoparticles, and stimuli-responsive systems designed to enhance drug delivery and reduce bacterial resistance. These systems facilitate precise targeting of biofilms, leveraging mechanisms such as enzyme-mediated degradation, quorum-sensing inhibition, and environment-responsive drug release. Furthermore, personalized medicine approaches, integrating pathogen-specific diagnostics and AI-driven optimization, hold promise for tailoring treatments to individual patient needs. Despite these breakthroughs, challenges such as toxicity concerns, scalability, and regulatory hurdles remain. Overcoming these barriers through interdisciplinary collaboration and continued research is essential to translate nanomedicine from laboratory success to clinical application. This paradigm shift in antimicrobial therapy has the potential to revolutionize the treatment of biofilm-related infections, significantly reducing global healthcare burdens and improving patient outcomes.

Zitieren

APA

Singh, R. (2025). Revolutionizing Antimicrobial Therapies Through Biofilm-Targeted Nanomedicine. Current Pharmaceutical Research. https://doi.org/10.63785/cpr.2025.1.1.7897

Vancouver

Singh R. Revolutionizing Antimicrobial Therapies Through Biofilm-Targeted Nanomedicine. Current Pharmaceutical Research. 2025. doi:10.63785/cpr.2025.1.1.7897

BibTeX
@article{Singh2025,
  author = {Singh, Robin},
  title = {Revolutionizing Antimicrobial Therapies Through Biofilm-Targeted Nanomedicine},
  journal = {Current Pharmaceutical Research},
  year = {2025},
  doi = {10.63785/cpr.2025.1.1.7897}
}
Kostenlos starten →